Idioma:

Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization

Nakoa, N ; Kamino, K ; Miura, K ; Hayashi, T ; Ohnishi, M ; Takayasu, Y ; Miura, T ; Okamoto, E

American journal of roentgenology (1976), 1991-06, Vol.156 (6), p.1177-1179 [Periódico revisado por pares]

Leesburg, VA: Am Roentgen Ray Soc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization
Autor: Nakoa, N ; Kamino, K ; Miura, K ; Hayashi, T ; Ohnishi, M ; Takayasu, Y ; Miura, T ; Okamoto, E
Assuntos: Antineoplastic Agents - therapeutic use ; Biological and medical sciences ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - therapy ; Doxorubicin - therapeutic use ; Embolization, Therapeutic ; Female ; Gelatin Sponge, Absorbable - therapeutic use ; Hepatectomy ; Hepatic Artery ; Humans ; Iodized Oil - therapeutic use ; Liver Neoplasms - mortality ; Liver Neoplasms - therapy ; Male ; Medical sciences ; Middle Aged ; Mitomycin ; Mitomycins - therapeutic use ; Neoplasm Recurrence, Local - therapy ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the digestive system ; Survival Rate
É parte de: American journal of roentgenology (1976), 1991-06, Vol.156 (6), p.1177-1179
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: The usefulness of transcatheter arterial chemoembolization (TACE) of the hepatic artery was retrospectively evaluated in 66 patients who underwent the procedure for treatment of hepatocellular carcinoma that recurred after partial hepatectomy. The materials infused were Gelfoam sponge or Gelfoam sponge plus Lipiodol and an anticancer agent. A control group of 15 patients with recurrent tumor received oral anticancer agents alone. The cumulative survival rate for the TACE group was 88% for the first year, 57% for 2 years, 42% for 3 years, and 27% for 5 years, whereas that of the control group was 80% for the first year, 27% for 2 years, and 18% for 3 years. Thus, the prognosis of the TACE group was significantly better (p less than or equal to .01, log-rank test) than that of the control group. The survival rate was inversely correlated with the ratio of the volume of the recurrent tumor to the volume of the whole residual liver. These results suggest that TACE is more effective than oral chemotherapy for treatment of hepatocellular carcinoma that recurs after partial hepatectomy.
Editor: Leesburg, VA: Am Roentgen Ray Soc
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization

Nakoa, N ; Kamino, K ; Miura, K ; Hayashi, T ; Ohnishi, M ; Takayasu, Y ; Miura, T ; Okamoto, E

Leesburg, VA: Am Roentgen Ray Soc

Buscando em bases de dados remotas. Favor aguardar.